• Protecting the health and well being of Albertans is a priority of this government.
• Arexvy was approved by Health Canada for use in adults 60 years of age and older on August 4, 2023.
• Alberta Health is awaiting guidance from the National Advisory Committee on Immunization (NACI) prior to making recommendations on the use of Arexvy in Alberta.
• Alberta Health will not be funding Arexvy for the upcoming RSV season.
• Once vaccine supply arrives in Canada this fall, this vaccine will be available for purchase in Alberta, and so individuals in the eligible population (60+) may choose to access Arexvy if it is covered through private health insurance or if they want to pay out-of-pocket.
Respiratory Syncytial Virus Vaccine
• Protecting the health and well being of Albertans is a priority of this government.
• Arexvy was approved by Health Canada for use in adults 60 years of age and older on August 4, 2023.
• Alberta Health is awaiting guidance from the National Advisory Committee on Immunization (NACI) prior to making recommendations on the use of Arexvy in Alberta.
• Alberta Health will not be funding Arexvy for the upcoming RSV season.
• Once vaccine supply arrives in Canada this fall, this vaccine will be available for purchase in Alberta, and so individuals in the eligible population (60+) may choose to access Arexvy if it is covered through private health insurance or if they want to pay out-of-pocket.
Read more here: Respiratory Syncytial Virus (RSV) Vaccine for adults who are 60+ years of age
Search
Recent Posts
Measles, Mumps, Rubella (MMR) Vaccine Information
July 18, 2025Accreditation Update – July 2025
July 2, 2025Refocusing Health Care in Alberta
January 10, 2025Newsletters
October 2, 2024What is Continuing Care?
February 2, 2024Popular Categories